{"data":{"id":799,"citation":"Curtis NJ, Mooney L, Hopcroft L, Michopoulos F, Whalley N, Zhong H, Murray C, Logie A, Revill M, Byth KF, Benjamin AD, Firth MA, Green S, Smith PD, Critchlow SE.: Pre-clinical pharmacology of AZD3965, a selective inhibitor of MCT1: DLBCL, NHL and Burkitt's lymphoma anti-tumor activity. Oncotarget, Volume 8 (41), 2017","title":"Pre-clinical pharmacology of AZD3965, a selective inhibitor of MCT1: DLBCL, NHL and Burkitt's lymphoma anti-tumor activity.","doi":"10.18632\/oncotarget.18215","doi_url":"https:\/\/doi.org\/10.18632\/oncotarget.18215","pmid":"29050199","pmid_url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/29050199\/","year":2017,"journal":"Oncotarget","volume":"8","issue":"41","page":"69219-69236","authors":[{"first_name":"Benjamin AD","last_name":null,"full_name":null},{"first_name":"Byth KF","last_name":null,"full_name":null},{"first_name":"Critchlow SE.","last_name":null,"full_name":null},{"first_name":"Curtis NJ","last_name":null,"full_name":null},{"first_name":"Firth MA","last_name":null,"full_name":null},{"first_name":"Green S","last_name":null,"full_name":null},{"first_name":"Hopcroft L","last_name":null,"full_name":null},{"first_name":"Logie A","last_name":null,"full_name":null},{"first_name":"Michopoulos F","last_name":null,"full_name":null},{"first_name":"Mooney L","last_name":null,"full_name":null},{"first_name":"Murray C","last_name":null,"full_name":null},{"first_name":"Revill M","last_name":null,"full_name":null},{"first_name":"Smith PD","last_name":null,"full_name":null},{"first_name":"Whalley N","last_name":null,"full_name":null},{"first_name":"Zhong H","last_name":null,"full_name":null}],"url":"https:\/\/molmedb.upol.cz\/api\/v1\/publications\/799","landing_page":"https:\/\/molmedb.upol.cz\/publication\/799","created_at":"2020-08-24T06:50:55.000000Z","updated_at":null}}